Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Apelin and its receptor APJ in cardiovascular diseases.

Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL, Zhang DW, Tian GP, Tang CK.

Clin Chim Acta. 2014 Jan 20;428:1-8. doi: 10.1016/j.cca.2013.09.001. Review.

PMID:
24055369
2.

Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.

Lv D, Li H, Chen L.

Acta Biochim Biophys Sin (Shanghai). 2013 Jul;45(7):527-33. doi: 10.1093/abbs/gmt040. Review.

PMID:
23588025
3.

Translational promise of the apelin--APJ system.

Barnes G, Japp AG, Newby DE.

Heart. 2010 Jul;96(13):1011-6. doi: 10.1136/hrt.2009.191122. Review.

PMID:
20584856
4.

Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells.

Lu Y, Zhu X, Liang GX, Cui RR, Liu Y, Wu SS, Liang QH, Liu GY, Jiang Y, Liao XB, Xie H, Zhou HD, Wu XP, Yuan LQ, Liao EY.

Amino Acids. 2012 Nov;43(5):2125-36. doi: 10.1007/s00726-012-1298-7.

PMID:
22532031
5.

Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.

Chu J, Zhang H, Huang X, Lin Y, Shen T, Chen B, Man Y, Wang S, Li J.

PLoS One. 2013;8(2):e57231. doi: 10.1371/journal.pone.0057231. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/15dd6d58-5cea-4252-94a6-52778c6ee55e.

6.

The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.

Japp AG, Newby DE.

Biochem Pharmacol. 2008 May 15;75(10):1882-92. doi: 10.1016/j.bcp.2007.12.015. Review.

PMID:
18272138
7.

[The role of apelin in pathogenesis of cardiovascular diseases and metabolic disorders].

Cudnoch Jędrzejewska A, Czarzasta K, Gomółka R, Szczepańska Sadowska E.

Kardiol Pol. 2011;69 Suppl 3:89-93. Review. Polish.

PMID:
22125210
8.

Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.

Falcão-Pires I, Leite-Moreira AF.

Rev Port Cardiol. 2005 Oct;24(10):1263-76. Review. English, Portuguese.

9.

In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.

Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA, Yue P, Huynh DT, Connolly AJ, Pelletier MP, Tsao PS, Robbins RC, Quertermous T.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H88-98.

10.

Apelin/APJ signaling in hypoxia-related diseases.

He L, Xu J, Chen L, Li L.

Clin Chim Acta. 2015 Dec 7;451(Pt B):191-8. doi: 10.1016/j.cca.2015.09.029. Review.

PMID:
26436483
11.

Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.

Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, Kundu RK, McLean DL, Kim JD, Park H, Jin SW, Hwa J, Quertermous T, Chun HJ.

Circ Res. 2013 Jun 21;113(1):22-31. doi: 10.1161/CIRCRESAHA.113.301324.

12.

Apelin and ACE2 in cardiovascular disease.

Kalea AZ, Batlle D.

Curr Opin Investig Drugs. 2010 Mar;11(3):273-82. Review.

PMID:
20178040
13.

Putative role for apelin in pressure/volume homeostasis and cardiovascular disease.

Charles CJ.

Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):1-10. Review.

PMID:
17266543
14.

Apelin protects heart against ischemia/reperfusion injury in rat.

Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, Tang CS.

Peptides. 2009 Jun;30(6):1144-52. doi: 10.1016/j.peptides.2009.02.010.

PMID:
19463748
15.

G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility.

Hashimoto Y, Ishida J, Yamamoto R, Fujiwara K, Asada S, Kasuya Y, Mochizuki N, Fukamizu A.

Int J Mol Med. 2005 Nov;16(5):787-92.

PMID:
16211245
16.

Apelin/APJ system: a promising therapy target for hypertension.

Wu D, He L, Chen L.

Mol Biol Rep. 2014 Oct;41(10):6691-703. doi: 10.1007/s11033-014-3552-4. Review.

PMID:
24990699
17.

Apelin/APJ signaling promotes hypoxia-induced proliferation of endothelial progenitor cells via phosphoinositide-3 kinase/Akt signaling.

Zhang J, Liu Q, Hu X, Fang Z, Huang F, Tang L, Zhou S.

Mol Med Rep. 2015 Sep;12(3):3829-34. doi: 10.3892/mmr.2015.3866.

PMID:
26018184
18.
19.

[Apelin--a new protein-regulator in the cardiovascular system].

Tereshchenko SN, Masenko VP, Cherkavskaia OV, Shashkova NV.

Ter Arkh. 2009;81(9):68-72. Review. Russian.

PMID:
19827657
20.

Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.

Cui RR, Mao DA, Yi L, Wang C, Zhang XX, Xie H, Wu XP, Liao XB, Zhou H, Meng JC, Yuan LQ, Liao EY.

Amino Acids. 2010 Nov;39(5):1193-200. doi: 10.1007/s00726-010-0555-x.

PMID:
20495838

Supplemental Content

Support Center